Selective inhibitors of protozoan protein N-myristoyltransferases as starting points for tropical disease medicinal chemistry programs.
Inhibition of N-myristoyltransferase has been validated pre-clinically as a target for the treatment of fungal and trypanosome infections, using species-specific inhibitors. In order to identify inhibitors of protozoan NMTs, we chose to screen a diverse subset of the Pfizer corporate collection agai...
Saved in:
| Main Authors: | Andrew S Bell, James E Mills, Gareth P Williams, James A Brannigan, Anthony J Wilkinson, Tanya Parkinson, Robin J Leatherbarrow, Edward W Tate, Anthony A Holder, Deborah F Smith |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2012-01-01
|
| Series: | PLoS Neglected Tropical Diseases |
| Online Access: | https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0001625&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MYC deregulation sensitizes cancer cells to N-myristoyltransferase inhibition
by: Gregor A. Lueg, et al.
Published: (2025-09-01) -
Inhibition of human N myristoyltransferase 1 as a strategy to suppress cancer progression driven by myristoylation
by: Mohammed Merae Alshahrani
Published: (2025-08-01) -
Phospholipases A and Lysophospholipases in protozoan parasites
by: Perrine Hervé, et al.
Published: (2023-10-01) -
Targeting n-myristoyltransferases promotes a pan-Mammarenavirus inhibition through the degradation of the Z matrix protein.
by: Xavier Carnec, et al.
Published: (2024-12-01) -
Inhibition of vaccinia virus L1 N-myristoylation by the host N-myristoyltransferase inhibitor IMP-1088 generates non-infectious virions defective in cell entry.
by: Lalita Priyamvada, et al.
Published: (2022-10-01)